Wall Street is anticipated to open quietly today as trading wraps up early at 1 p.m. ET, marking the beginning of the holiday season’s Santa Claus rally, which spans the last five trading days of the year and the first two of the following year. The S&P 500 recently achieved another record close, largely propelled by enthusiasm in the AI technology sector, despite lighter trading volumes observed yesterday.
In economic news, initial jobless claims for the previous week came in at 214,000, lower than the Dow Jones consensus estimate of 225,000 and an improvement from 224,000 in the week prior. However, continuing jobless claims did rise to 1.923 million, breaking a trend of being under 1.9 million for two weeks.
Nike shares experienced a 2% increase this morning, bolstered by the news that board member Tim Cook, also the CEO of Apple, purchased nearly $3 million worth of stock in the company on Monday. Another director, Bob Swan, former CEO of Intel, also bought around $500,000 in Nike shares. This insider buying is viewed as a strong vote of confidence in the company.
Conversely, Intel’s stock fell nearly 3% following a report from Reuters indicating that Nvidia, another company within the Club, tested Intel’s manufacturing process for its chips but did not proceed. This news emerged in a broader piece about new Intel CEO Lip-Bu Tan’s interactions in Washington as the company strives to improve its foundry capabilities.
In a positive outlook, Cantor Fitzgerald suggested that Nvidia and Broadcom, both part of the Club, might be positioned for significant outperformance when the new year begins. Analysts noted that despite recent pressures on AI stocks, they believe the concerns are exaggerated and overlook the forthcoming surge in AI-related demand.
Meanwhile, Barclays has adjusted its price target for Honeywell, lowering it to $250 from $269. Nonetheless, the new target represents nearly 38% potential upside from Wednesday’s closing price. Analysts reiterated their buy rating, believing interest in Honeywell will grow as the spin-off of its aerospace division approaches next year.
In corporate news, BP has agreed to sell its 65% stake in the Castrol lubricants business to the investment firm Stonepeak for about $10 billion in enterprise value, leading to roughly $6 billion in net proceeds for BP. The energy giant plans to allocate these funds to reduce its debt while shifting its focus back to core fossil fuel operations.
In healthcare developments, the Trump administration announced a voluntary test for a new payment model for GLP-1 weight-loss drugs under Medicare Part D plans and state-level Medicaid programs. This initiative builds on a prior price-cut agreement reached between the administration and obesity drug manufacturers Novo Nordisk and Eli Lilly to expand Medicare coverage.
President Trump stated in a recent social media post that he expects the new Federal Reserve chair to lower interest rates if market conditions are favorable, emphasizing the importance of investor confidence in the Fed’s leadership. Current Fed Chair Jerome Powell’s term concludes in May 2026, presenting challenging conditions for his successor.
Lastly, French pharmaceutical firm Sanofi has entered into a $2.2 billion agreement to acquire Dynavax Technologies, a vaccine manufacturer, leading to a notable rise of over 39% in Dynavax’s stock prices. This acquisition will enable Sanofi to add an approved hepatitis B vaccine to its portfolio.
For more insights and updates on market movements, you can subscribe to the Top 10 Morning Thoughts on the Market email newsletter, which provides timely notifications before significant trades.
